WeVote
Log In

Bill

Bill

SB 196

AN ACT LIMITING CHANGES TO PRESCRIPTION DRUG FORMULARIES FOR PSYCHIATRIC PRESCRIPTION DRUGS.

2025 Regular Session Introduced by Heather Somers

Connecticut bill restricts insurers from changing psychiatric drug formularies, protecting medication continuity for mental health patients but potentially limiting cost-control options.

REF. TO JOINT COMM. ON Insurance and Real Estate
#drugs #healthinsurance #psychiatryandpsychiatrists
0
WeVote Research Nonpartisan
Bill Summary · SB 196

Legislative bill overview

SB 196 would restrict insurance companies' ability to make changes to their prescription drug formularies (the list of covered medications) specifically for psychiatric medications. The bill aims to provide greater stability and predictability for patients with mental health conditions who rely on specific antipsychotic, antidepressant, anti-anxiety, or mood-stabilizing drugs.

Why is this important

Psychiatric patients often experience significant challenges when their medications are suddenly changed or removed from coverage due to formulary changes—switching drugs can destabilize treatment, trigger symptom relapse, or force costly out-of-pocket expenses. Limiting these changes could improve treatment continuity and outcomes for people with serious mental illness, though it may affect insurers' ability to manage drug costs and negotiate with pharmaceutical manufacturers.

Potential points of contention

  • Cost implications: Restrictions on formulary changes may limit insurers' ability to negotiate lower prices or substitute more cost-effective drugs, potentially increasing premiums for all policyholders
  • Scope and specificity: The bill treats psychiatric drugs differently than other equally critical medications (cardiovascular, cancer treatments), raising questions about whether this distinction is justified or creates problematic precedent
  • Implementation details: Unclear whether the bill allows any formulary changes for psychiatric drugs or only certain types; overly strict limitations could prevent coverage of newer, safer medications with fewer side effects

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.